Total Payments
$6,574
2024 Payments
$524.81
Companies
7
Transactions
65
Medicare Patients
3,751
Medicare Billing
$588,777
Payment Breakdown by Category
Consulting$3,000 (45.6%)
Food & Beverage$2,270 (34.5%)
Travel$1,189 (18.1%)
Education$115.58 (1.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,000 | 1 | 45.6% |
| Food and Beverage | $2,270 | 58 | 34.5% |
| Travel and Lodging | $1,189 | 3 | 18.1% |
| Education | $115.58 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $5,402 | 36 | $0 (2024) |
| ViiV Healthcare Company | $392.87 | 13 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $223.67 | 4 | $0 (2018) |
| Allergan Inc. | $202.79 | 8 | $0 (2019) |
| Janssen Products, LP | $200.41 | 2 | $0 (2021) |
| Integra LifeSciences Corporation | $139.90 | 1 | $0 (2022) |
| PFIZER INC. | $11.83 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $524.81 | 16 | Gilead Sciences, Inc. ($272.98) |
| 2023 | $12.94 | 1 | ViiV Healthcare Company ($12.94) |
| 2022 | $268.00 | 6 | Integra LifeSciences Corporation ($139.90) |
| 2021 | $287.43 | 6 | Gilead Sciences, Inc. ($188.43) |
| 2020 | $20.34 | 1 | Gilead Sciences, Inc. ($20.34) |
| 2019 | $374.78 | 9 | Gilead Sciences, Inc. ($261.04) |
| 2018 | $335.24 | 12 | Gilead Sciences, Inc. ($133.88) |
| 2017 | $4,750 | 14 | Gilead Sciences Inc ($4,526) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.60 | General |
| 12/17/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: HIV | ||||||
| 12/03/2024 | Gilead Sciences, Inc. | Veklury (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: COVID-19 | ||||||
| 11/21/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $31.35 | General |
| Category: HIV | ||||||
| 11/06/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.43 | General |
| 11/04/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $41.87 | General |
| 10/23/2024 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $28.03 | General |
| Category: HIV | ||||||
| 10/17/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $25.03 | General |
| Category: HIV | ||||||
| 10/09/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $33.46 | General |
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $32.16 | General |
| 08/14/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $29.45 | General |
| 08/12/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: HIV | ||||||
| 05/02/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $34.71 | General |
| 04/17/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $28.33 | General |
| 03/05/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $30.20 | General |
| Category: HIV | ||||||
| 02/27/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $93.25 | General |
| Category: HIV | ||||||
| 06/23/2023 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: HIV | ||||||
| 12/12/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $115.29 | General |
| Category: HIV | ||||||
| 10/19/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.03 | General |
| Category: HIV | ||||||
| 10/10/2022 | Integra LifeSciences Corporation | Integra (Device), Integra, Integra | Food and Beverage | In-kind items and services | $139.90 | General |
| Category: Recon-Skin and Wound | ||||||
| 10/10/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $5.38 | General |
| Category: HIV | ||||||
| 09/29/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $1.50 | General |
| Category: HIV | ||||||
| 02/08/2022 | ViiV Healthcare Company | DOVATO (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: HIV | ||||||
| 10/21/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $95.59 | General |
| 10/05/2021 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $23.08 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 864 | 1,478 | $410,791 | $143,184 |
| 2022 | 7 | 1,017 | 1,698 | $449,359 | $151,755 |
| 2021 | 7 | 937 | 1,626 | $434,225 | $148,901 |
| 2020 | 6 | 933 | 1,499 | $412,912 | $144,936 |
Total Patients
3,751
Total Services
6,301
Medicare Billing
$588,777
Procedure Codes
25
All Medicare Procedures & Services
25 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 367 | 876 | $233,393 | $85,460 | 36.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 381 | 447 | $146,616 | $47,824 | 32.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 100 | $20,925 | $6,392 | 30.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 53 | 55 | $9,857 | $3,509 | 35.6% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 427 | 1,007 | $251,750 | $84,919 | 33.7% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 401 | 454 | $148,912 | $50,550 | 33.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 64 | 96 | $17,860 | $6,444 | 36.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 60 | 69 | $11,937 | $3,986 | 33.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 29 | 35 | $8,785 | $2,885 | 32.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 23 | 23 | $7,590 | $2,179 | 28.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 13 | 14 | $2,525 | $792.37 | 31.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 394 | 1,000 | $250,000 | $85,329 | 34.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 416 | 460 | $150,880 | $51,672 | 34.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 43 | 63 | $11,340 | $4,285 | 37.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 42 | 47 | $8,131 | $2,645 | 32.5% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 15 | 23 | $6,049 | $2,202 | 36.4% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 13 | 13 | $4,225 | $1,466 | 34.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 14 | 20 | $3,600 | $1,303 | 36.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 334 | 793 | $198,250 | $70,475 | 35.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 448 | 510 | $167,280 | $59,654 | 35.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 80 | 118 | $31,034 | $9,258 | 29.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 34 | 39 | $6,747 | $2,441 | 36.2% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Facility | 2020 | 12 | 12 | $3,960 | $1,376 | 34.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 14 | 16 | $2,880 | $982.44 | 34.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 11 | 11 | $2,761 | $748.85 | 27.1% |
About Dilraj Deol
Dilraj Deol is a Specialist healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2009. The National Provider Identifier (NPI) number assigned to this provider is 1356578058.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dilraj Deol has received a total of $6,574 in payments from pharmaceutical and medical device companies, with $524.81 received in 2024. These payments were reported across 65 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($3,000).
As a Medicare-enrolled provider, Deol has provided services to 3,751 Medicare beneficiaries, totaling 6,301 services with total Medicare billing of $588,777. Data is available for 4 years (2020–2023), covering 25 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Infectious Disease
- Location Baltimore, MD
- Active Since 06/19/2009
- Last Updated 06/20/2019
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1356578058
Products in Payments
- Epclusa (Drug) $4,625
- DOVATO (Drug) $169.07
- Integra (Device) $139.90
- CABENUVA (Biological) $123.45
- Biktarvy (Drug) $120.30
- Descovy (Drug) $115.99
- ZEPATIER (Drug) $109.85
- DALVANCE (Drug) $102.92
- Symtuza (Drug) $101.41
- APRETUDE (Biological) $100.35
- AVYCAZ (Drug) $99.87
- SYMTUZA (Drug) $99.00
- ISENTRESS (Drug) $97.24
- PIFELTRO (Drug) $16.58
- Veklury (Drug) $11.97
- CHANTIX (Drug) $11.83
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Baltimore
Mr. James Gammie, M.d, M.D
Specialist — Payments: $29.8M
Specialist $29.8M
Dr. Richard Adler, M.d, M.D
Specialist — Payments: $3.1M
Specialist $3.1M
Dr. Philip Levin, M.d, M.D
Specialist — Payments: $921,481
Specialist $921,481
Dr. Agha Khan, Md, MD
Specialist — Payments: $170,581
Specialist $170,581
W. Eglseder, M.d, M.D
Specialist — Payments: $57,679
Specialist $57,679
Bartley Griffith, M.d, M.D
Specialist — Payments: $49,695
Specialist $49,695